Reduction in the elevated blood pressure of Dahl salt-sensitive rats treated chronically with L-5-hydroxytryptophan

Pharmacology. 1991;42(1):15-22. doi: 10.1159/000138763.

Abstract

Rats of the Dahl salt-sensitive (DS) and Dahl salt-resistant (DR) strains were placed on a 4% NaCl diet and blood pressures were monitored. Chronic subcutaneous infusion L-5-hydroxytryptophan (L-5-HTP, 12.6 mg/day) by osmotic minipumps significantly decreased the elevated systolic blood pressure of DS rats on a 4% NaCl diet. Blood pressures of DR rats were unaffected by treatment with L-5-HTP. Cardiac hypertrophy was associated with Dahl salt-induced hypertension. However, treatment with L-5-HTP failed to reduce the weight of the heart significantly. These results suggest that chronic administration of L-5-HTP was effective in reducing the elevated blood pressure in the DS model. The specific mechanisms by which L-5-HTP reduces the elevated blood pressure in DS rats is not clear and remains for further study.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 5-Hydroxytryptophan / pharmacology*
  • Animals
  • Blood Pressure / drug effects*
  • Body Weight / drug effects
  • Cardiomegaly / physiopathology
  • Desoxycorticosterone
  • Female
  • Hypertension / chemically induced
  • Hypertension / genetics
  • Hypertension / physiopathology
  • Organ Size / drug effects
  • Rats
  • Rats, Inbred Strains

Substances

  • Desoxycorticosterone
  • 5-Hydroxytryptophan